Mylan Inc (NASDAQ:MYL)

57.33
Delayed Data
As of Feb 27
 +0.08 / +0.14%
Today’s Change
44.74
Today|||52-Week Range
59.60
+1.69%
Year-to-Date

Today’s Trading

Previous close57.25
Today’s open57.92
Day’s range56.89 - 58.37
Volume5,229,157
Average volume (3 months)3,153,083
Market cap$21.5B
Dividend yield--
Data as of 4:14pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+3.95%
Earnings growth (this year)+22.94%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+1.89%
P/E ratio24.7
Price/Sales2.39
Price/Book7.24

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.78-0.50%
ZTSZoetis Inc-0.53-1.14%
BMRNBiomarin Pharmaceuti...-1.77-1.63%
PCYCPharmacyclics Inc-1.89-0.87%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)$1.05
Annual revenue (last year)$7.0B
Annual profit (last year)$623.7M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Canonsburg, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account